October 28, 2026
mayank
ITI Pharma and Healthcare Fund
| Fund at a Glance | |
| NAV Growth (Rs.) | 18.47 |
| NAV IDCW (Rs.) | 18.47 |
| Bonus NaV (Rs.) | — |
| Min. Investment (Rs.) | 5,000 |
| Min. SIP Investment (Rs) | 500 |
| Min. No of Cheques | 12 |
| Benchmark | NIFTY Healthcare TRI. |
| AUM Rs. | 266 Cr |
| (As on 30-Sep-2026) | |
| Expense | 0.58% |
| 1 Year Return (%) | 1.92 |
| 3 Year Return (%) | 17.78 |
| 5 Year Return (%) | — |
| 10 Year Return (%) | — |
| Return Since Launch | 12.96% |
Suitable For Which Investors?
Pharma funds are suitable for investors:
1. Wanting a small, supporting exposure to the pharmaceutical and healthcare sector
2. Aiming for long term wealth creation
3. With a 7+ year investment horizon, who can withstand the sharper swings of a concentrated portfolio
Note:
• Most investors can skip these funds and stick to diversified equity funds instead
• If you choose to invest, do so only through SIP
Fund’s Investment Strategy:
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.
Fund Manager:
1) Animesh Singh
Education: Post Graduate Diploma in Management, Bachelor of Honours -(Economics) CFA – USA Certification.
Experience: Prior to joining the ITI AMC, he was associated with Julius Baer wealth Advisor, Centrum Wealth, Nippon Life India Asset Management Ltd, Reliance Portfolio Management Services, KSBL and SSKI Securities.
2) Nilay Dalal
Education: Mr. Nilay holds a degree in B.E (Computer) from D.J Sanghvi College of Engg & master’s in management studies in KJ Somaiya Institute of Management Studies & Research.
Experience: Prior to joining ITI Mutual Fund, he has with Axis Asset Management Company, SBI Life Insurance Company Ltd & MAQ Software Pvt Ltd.
Investment Details
| Min. Investment (Rs) | 5,000 |
| Min. Addl Investment (Rs) | 1,000 |
| Min. SIP Investment (Rs) | 500 |
| Min. Withdrawal (Rs) | 1,000 |
| Min. No of Cheques | 12 |
| Min. Balance (Rs) | — |
| Lock-in Period | NA |
| Exit Load | 0.5% for redemption within 3 months |
Basic Details of ITI Pharma and Healthcare Fund
| Fund House | ITI Mutual Fund |
| Launch Date | 08-Nov-21 |
| Return Since Launch | 12.96% |
| Benchmark | NIFTY Healthcare TRI. |
| Riskometer | Very High |
| Type | Open-ended |
| Assets | 266 Cr |
| (As on 30-Sep-2026) | |
| Expense | 0.58% |
| (As on 30-Sep-2026) | |
| Risk Grade | Above Average |
| Return Grade | Below Average |
| Turnover | 47.00% |
ITI Pharma and Healthcare Fund Trailing Returns (%)
| Fund name | YTD | 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | 7Y | 10Y |
| ITI Pharma and Healthcare Dir | 7.25 | -0.94 | -9.93 | -4.59 | 6.43 | 1.92 | 17.78 | — | — | — |
| BSE Healthcare TRI | 7.71 | -0.89 | -9.95 | -5.14 | 6.53 | 4.35 | 20.13 | — | — | — |
| Equity: Sectoral-Pharma | 8.88 | -0.89 | -9.76 | -4.91 | 7.27 | 6.45 | 20.20 | — | — | — |
| Rank within category | 17 | 16 | 14 | 12 | 17 | 21 | 12 | — | — | — |
| Number of funds in category | 24 | 26 | 26 | 25 | 25 | 23 | 14 | 10 | 9 | 4 |
Peer Comparison of ITI Pharma and Healthcare Fund
| Rating | 1 Year Returns | 3 Year Returns | 5 Year Returns | Expense Ratio (%) | Net Assets (Rs Cr) | Return Since Launch (%) | Exit Load (Days) | Fund Age | Turnover (%) | |
| ITI Pharma and Healthcare Dir | 2 out of 5 stars | 1.92 | 17.78 | — | 0.58 | 266 | 12.96 | 0.50 (90) | 4Y 11M | 47.00 |
| ICICI Pru Healthcare Dir | 4 out of 5 stars | -0.84 | 20.01 | 15.13 | 0.89 | 6,861 | 19.41 | 1.00 (15) | 8Y 3M | 76.00 |
| SBI Healthcare Opportunities Dir | 5 out of 5 stars | 8.45 | 21.81 | 17.39 | 0.73 | 5,870 | 17.34 | 0.50 (15) | 13Y 9M | 34.00 |
| UTI Healthcare Dir | 4 out of 5 stars | 6.98 | 21.10 | 14.75 | 1.05 | 1,430 | 15.63 | 1.00 (30) | 13Y 9M | 32.00 |
| Nippon India Pharma Dir | 2 out of 5 stars | 2.60 | 16.34 | 12.86 | 0.79 | 9,166 | 16.72 | 1.00 (30) | 13Y 9M | 15.00 |
ITI Pharma and Healthcare Fund Portfolio Analysis
| No. of Stocks | 37 |
| Top 10 Stocks | 56.97% |
| Top 5 Stocks | 36.48% |
| Top 3 Sectors | 99.31% |
| Portfolio P/B Ratio | 5.87 |
| Portfolio P/E Ratio | 47.14 |
Portfolio Breakup
| Fund | Category | |
| Average Mkt Cap (Rs Cr) | 87,231 | 86,489 |
| Large (%) | 36.14 | 35.31 |
| Mid (%) | 40.73 | 40.58 |
| Small (%) | 23.13 | 27.23 |
Note: Mutual fund investments are subject to market risks, read all scheme-related documents carefully.
Apply Online: https://investonline.itiamc.com/login
>> Post your MF questions @ sahifund.com/ask-me/
>> NFO Guidance: https://sahifund.com/category/nfos/
Quicklinks